Patrick Messner-Pellenc, MD, PhD

Original Contribution

Safety of Percutaneous Coronary Intervention Without P2Y12 Inhibitor Pretreatment From a Cohort of Unselected Patients

07/15/2018

Pierre Robert , MD;

Patrick Messner-Pellenc , MD, PhD;

Florence Leclercq , MD, PhD;

Guillaume Cayla , MD, PhD;

Benoit Lattuca , MD;

David Belardi , MD;

Christophe Demattei , MD;

Laurent Schmutz , MD;

Luc Cornillet , MD;

Bertrand Ledermann , MD;

Jean-Christophe Macia , MD;

A. Lemmi , MD;

Richard Gervasoni , MD;

Francois Roubille , MD, PhD;

Thien Tri Cung , MD;

Recent studies have challenged systematic pretreatment with a P2Y12 inhibitor before PCI in elective and NSTEMI patients. This study assesses outcomes after performing PCI immediately after coronary angiography with an exclusive...

Recent studies have challenged...

07/15/2018

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8

November 8 ⁠–⁠ November 10

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Patrick Messner-Pellenc, MD, PhD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products